John R. Dunn,
Ph.D., Chief Technical Officer, Brendan Technologies, Inc.
Dr. Dunn's research has been a researcher in the fields of tumor cell metabolism, endocrinology, radiology and pharmacology. Dr. Dunn has extensive research and laboratory management experience from several industry positions, including setting up and running a high-volume reference laboratory specializing in immunochemistry. He also was a consultant for assay developï¿½ment and statistics for several laboratories, and served as a technical advisor for several diagnostic reagent manufacturers. Dr. Dunn is founder and head of the development team which manufactures StatLIA, data analysis and management software for the biopharmaceutical and research communities. He conducts training classes and consultations at biopharmaceutical, diagnostic and reagent manufacturers in the U.S. and Europe.